@article{d54232bcadb04a8bb69d2f2cf99193a4,
title = "Canadian Urological Association guideline on the management of non-muscle-invasive bladder cancer – Abridged version",
author = "Bimal Bhindi and Ronald Kool and Kulkarni, {Girish S.} and {Robert Siemens}, D. and Aprikian, {Armen G.} and Breau, {Rodney H.} and Fadi Brimo and Adrian Fairey and Christopher French and Nawar Hanna and Izawa, {Jonathan I.} and Louis Lacombe and Victor McPherson and Rendon, {Ricardo A.} and Bobby Shayegan and So, {Alan I.} and Zlotta, {Alexandre R.} and Black, {Peter C.} and Wassim Kassouf",
note = "Funding Information: Competing interests: Dr. Bhindi has been an advisory board member for Bayer and Janssen; and has received speaker honoraria from Merck. Dr. Kulkarni has been an advisory board member for Astellas, Ferring, Janssen, Merck, Roche, and Theralase; has received grants and/or honoraria from Abbvie, Ferring, Sanofi, and TerSera; and has participated in clinical trials supported by Merck, Astra Zeneca, Bristol Myers Squibb, Janssen, and Theralase. Dr. Siemens has participated in clinical trials supported by Astellas, Merck, and Pfizer. Dr. Aprikian has been an advisory board member for Abbvie, Astellas, and Bayer; and has received grants and/or honoraria from Abbvie, Astellas, Bayer, Sanofi, and TerSera. Dr. Hanna has received honoraria from Astellas and Bayer; and has participated in clinical trials supported by Merck. Dr. Izawa has received honoraria from Abbvie. Dr. McPherson has been an advisory board member for Abbvie and TerSera; has received travel funding from TerSera; and has participated in clinical trials supported by Bristol-Myers Squibb and Pfizer. Dr. Rendon has been an advisory board member for Abbvie, Amgen, Astellas, AstraZeneca, Bayer, Ferring, Janssen, Pfizer, Roche, and Sanofi; a speakers{\textquoteright} bureau member for Abbvie, Amgen, Astellas, AstraZeneca, Bayer, Ferring, Janssen, Pfizer, Roche , and Sanofi; has received grants and/or honoraria from Abbvie, Astellas, Bayer, Ferring, Janssen, and Sanofi; holds investments in Myovant; and has participated in clinical trials supported by Abbvie, Astellas, Bayer, Bavarian Nordic, Ferring, Janssen, Myovant, and Sanofi. Dr. Shayegan has been an advisory board member for AbbVie, Astellas, Bayer, Ferring Janssen, Knight, Merck, Pfizer, Sanofi, and TerSera; and has participated in clinical trials supported by Ipsen, Janssen, Merck, Myovant, and Pfizer. Dr. So has been an advisory board member for Abbvie, Amgen, Astellas, Bayer, Janssen, Ferring, and TerSera; and has participated in clinical trials supported by Astellas, Ferring, and Janssen. Dr. Zlotta has been an advisory board member for AstraZeneca, Ferring, Janssen, Merck, Sanofi, and Verity. Dr. Black has been an advisory board member for AbbVie, Asieris, Astellas, AstraZeneca, Bayer, Biosyent, BMS, EMD-Serono, Ferring, Fergene, H3-Biomedicine, Janssen, Merck, Protara Therapeutics, Roche, Sanofi, and Urogen; a speakers{\textquoteright} bureau member for AbbVie, Biosyent, Ferring, Janssen, Pfizer, and TerSera; has received payment from Bayer and Sanofi; has received grants and/or honoraria from iProgen; holds a patent marketed by Decipher Biosciences; and has participated in clinical trials supported by Astellas, AstraZeneca, BMS, Genentech, Janssen, MDx Health, Pacific Edge, and Therelase. Dr. Kassouf has been an advisory board member for EMD Serono and Pfizer; has received grants and/or honoraria from Abbvie, Astellas, BMS, Ferring, Janssen, Merck, Roche, and Sesen Bio; and has participated in clinical trials supported by Astra Zeneca, BMS, Janssen, Pfizer, Roche, Sesen Bio, and Theralase. No other authors report any competing personal or financial interests related to this work.",
year = "2021",
month = aug,
doi = "10.5489/CUAJ.7487",
language = "English",
volume = "15",
pages = "230--239",
journal = "Journal of the Canadian Urological Association",
issn = "1911-6470",
publisher = "Canadian Medical Association",
number = "8",
}
